Vidi V - Search Results

1

Multivessel percutaneous coronary intervention without contrast agents.

Vidi VD, Barseghian A, Garratt KN. Vidi VD, et al. Catheter Cardiovasc Interv. 2016 Dec;88(7):E222-E226. doi: 10.1002/ccd.26370. Epub 2015 Dec 28. Catheter Cardiovasc Interv. 2016. PMID: 26708315

2

Vascular closure device failure in contemporary practice.

Vidi VD, Matheny ME, Govindarajulu US, Normand SL, Robbins SL, Agarwal VV, Bangalore S, Resnic FS. Vidi VD, et al. JACC Cardiovasc Interv. 2012 Aug;5(8):837-44. doi: 10.1016/j.jcin.2012.05.005. JACC Cardiovasc Interv. 2012. PMID: 22917455 Free PMC article.

3

Testosterone supplementation in heart failure: a meta-analysis.

Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, Armstrong PW, Ezekowitz JA. Toma M, et al. Among authors: vidi v. Circ Heart Fail. 2012 May 1;5(3):315-21. doi: 10.1161/CIRCHEARTFAILURE.111.965632. Epub 2012 Apr 17. Circ Heart Fail. 2012. PMID: 22511747 Review.

4

Quantifying the learning curve in the use of a novel vascular closure device: an analysis of the NCDR (National Cardiovascular Data Registry) CathPCI registry.

Resnic FS, Wang TY, Arora N, Vidi V, Dai D, Ou FS, Matheny ME. Resnic FS, et al. Among authors: vidi v. JACC Cardiovasc Interv. 2012 Jan;5(1):82-9. doi: 10.1016/j.jcin.2011.09.017. JACC Cardiovasc Interv. 2012. PMID: 22230153 Free article.

5

Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing.

Matheny ME, Normand SL, Gross TP, Marinac-Dabic D, Loyo-Berrios N, Vidi VD, Donnelly S, Resnic FS. Matheny ME, et al. Among authors: vidi vd. BMC Med Inform Decis Mak. 2011 Dec 14;11:75. doi: 10.1186/1472-6947-11-75. BMC Med Inform Decis Mak. 2011. PMID: 22168892 Free PMC article.

6

Efficacy and safety of the nitinol clip-based vascular closure device (Starclose) for closure of common femoral arterial cannulation at or near the bifurcation: a propensity score-adjusted analysis.

Bangalore S, Vidi VD, Liu CB, Shah PB, Resnic FS. Bangalore S, et al. Among authors: vidi vd. J Invasive Cardiol. 2011 May;23(5):194-9. J Invasive Cardiol. 2011. PMID: 21562348

7

Post-marketing device safety surveillance.

Vidi VD, Matheny ME, Resnic FS. Vidi VD, et al. Contemp Clin Trials. 2011 May;32(3):307-8. doi: 10.1016/j.cct.2011.02.002. Epub 2011 Feb 28. Contemp Clin Trials. 2011. PMID: 21371573 No abstract available.

8

An evaluation of a distributed medical device safety surveillance system: the DELTA network study.

Vidi VD, Matheny ME, Donnelly S, Resnic FS. Vidi VD, et al. Contemp Clin Trials. 2011 May;32(3):309-17. doi: 10.1016/j.cct.2011.02.001. Epub 2011 Feb 26. Contemp Clin Trials. 2011. PMID: 21356331 Free PMC article.

9

Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention.

Vidi VD, Matheny ME, Agarwal V, Arora N, Donnelly S, Bangalore S, Resnic FS. Vidi VD, et al. Am J Cardiol. 2010 Nov 1;106(9):1234-40. doi: 10.1016/j.amjcard.2010.06.047. Epub 2010 Sep 9. Am J Cardiol. 2010. PMID: 21029818 Free PMC article.

10

Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentation and outcomes.

Vidi VD, Arora N. Vidi VD, et al. J Invasive Cardiol. 2010 Jun;22(6):271-2. J Invasive Cardiol. 2010. PMID: 20516506 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters